5 hrs ago | MedicineNet
Menstrual Periods: Clues to Ovarian Cancer
July 9, 2009 -- A woman's hormonal activity over her lifetime affects her risk of dying from ovarian cancer , according to a new study.
EDITORIAL: A matter of biology, genetics?
But why do some fear these study results? For decades it's been assumed poor people and minorities are likely to live shorter, sicker lives, and are likely to die earlier from a host of illnesses , because poor people and minorities get inferior care.
New Drug Holds Promise In Some Cancer Cases
Results of a limited clinical trial of a new cancer drug may be encouraging for patients with some difficult types of cancer.
Two Reproductive Factors are Important Predictors of Death from Ovarian Cancer
Researchers from the Centers for Disease Control and Prevention found that survival among women with ovarian cancer is influenced by age of menarche and total number of lifetime ovulatory cycles.
Ovarian Cancer Can Slip by Tests - July 09, 2009
Numerous times after Amy Brannock was diagnosed and treated for ovarian cancer, a screening test showed her illness remained in remission.
Shedding Light On Racial Disparities In Cancer Survival - 2 Studies
Main Category: Breast Cancer Also Included In: Prostate / Prostate Cancer ; Ovarian Cancer Article Date: 08 Jul 2009 - 3:00 PDT printer friendly view / write opinions rate article Black women diagnosed with breast cancer have a greater chance of dying from the disease than white women, according to a new study published online July 7 in the Journal ...
Some cancers hit blacks harder
WASHINGTON - African-Americans are less likely than whites to survive breast, prostate and ovarian cancer even when they receive equal treatment, according to a large study that offers provocative evidence that biological factors play a role in at least some racial disparities.
In this factsheet: The Facts on Prostate Cancer Prostate cancer is the cancer most often diagnosed in Canadian men.
New Hope for Over-Charged Health Insurance Customers
Mary Reinbold Jerome doesn't know how much time she has left. Mary Reinbold Jerome, an ovarian cancer patient, was shocked by how little her insurer would pay to cover her treatments.
Intravenous COTI-2 In Combination With Doxil (Doxorubicin...
Critical Outcome Technologies Inc. , announced positive results today from combination agent animal experiments carried out at a prominent American cancer research facility.
Vegetarians are less likely to develop cancer than meat eaters, according to several newspapers.
UNCW nursing students try to raise scholarship money
UNCW nursing students are hosting a fundraiser to help aid the Kay Whitfield School of Nursing Endowed Scholarship.
European Urology July Issue Reviews Prostate Screening Studies
The July issue of European Urology , the official journal of the European Association of Urology, features an editorial by Lars Holmberg comparing the results from the European Randomised Study of Screening for Prostate Cancer with the results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial In the editorial, Professor ...
Ovarian cancer sufferers are 'dying unnecessarily' as doctors confuse symptoms with IBS
Lives may be lost because ovarian cancer is misunderstood and mistaken for bowel problems, a report said today.
Widespread Confusion About Ovarian Cancer Signs Says UK Charity
There is widespread confusion among women and doctors about the signs of ovarian cancer, said a UK charity behind a study being published today, Monday 29 June, at the House of Commons.
Ovary cancer signs 'confusion'
There is "widespread confusion" amongst doctors and women about ovarian cancer, a charity has said.
Some promising news on the health care front, specifically the fight against breast and ovarian cancer.
Platypus link to ovarian cancer
Researchers from the Royal Adelaide Hospital and University of Adelaide believe our oldest mammalian relative may help us to better understand ovarian cancer.
New Drug Targeting Cancer Weakness Shows Great Promise
Main Category: Breast Cancer Also Included In: Ovarian Cancer ; Prostate / Prostate Cancer ; Cancer / Oncology Article Date: 25 Jun 2009 - 4:00 PDT Scientists at The Institute of Cancer Research and The Royal Marsden Hospital, working with pharmaceutical company AstraZeneca, have completed a Phase I clinical trial demonstrating the great promise of ...
New Cancer Drug Fights Tumors in Those With BRCA Mutations
A new cancer drug called olaparib worked well in an early clinical trial against breast, ovarian and prostate cancers in individuals who were genetically vulnerable to developing these malignancies.